Cargando…
High risk of renal dysfunction in patients with fulminant type 1 diabetes
AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diab...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754524/ https://www.ncbi.nlm.nih.gov/pubmed/28267278 http://dx.doi.org/10.1111/jdi.12652 |
_version_ | 1783290434250866688 |
---|---|
author | Takahashi, Nobuyuki Tsujimoto, Tetsuro Chujo, Daisuke Kajio, Hiroshi |
author_facet | Takahashi, Nobuyuki Tsujimoto, Tetsuro Chujo, Daisuke Kajio, Hiroshi |
author_sort | Takahashi, Nobuyuki |
collection | PubMed |
description | AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes diagnosed during April 1993 to March 2016 at a national center in Japan. Glycated hemoglobin levels, incidence rates of renal dysfunction defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) and microalbuminuria were examined. RESULTS: In total, 115 patients with type 1 diabetes (10 with fulminant type 1 diabetes and 105 with acute‐onset type 1 diabetes) were included. The median glycated hemoglobin levels were significantly lower in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes 0, 3, 6 and 9 years after diabetes onset (6.5 vs 12.7%, 6.5 vs 7.9%, 6.7 vs 8.2%, 7.5 vs 8.5%, respectively). Kaplan–Meier analysis showed a significantly higher incidence rate of renal dysfunction in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes (hazard ratio 1.72, 95% confidence interval 1.01–2.97, P = 0.037). The incidence rate of microalbuminuria did not significantly differ between the groups (hazard ratio 0.97, 95% confidence interval 0.34–2.77, P = 0.95). Sensitivity analysis using age‐ and sex‐matched patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes yielded similar results. CONCLUSIONS: The risk of developing renal dysfunction is higher in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes, despite better glycemic control. |
format | Online Article Text |
id | pubmed-5754524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57545242018-01-09 High risk of renal dysfunction in patients with fulminant type 1 diabetes Takahashi, Nobuyuki Tsujimoto, Tetsuro Chujo, Daisuke Kajio, Hiroshi J Diabetes Investig Articles AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes diagnosed during April 1993 to March 2016 at a national center in Japan. Glycated hemoglobin levels, incidence rates of renal dysfunction defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) and microalbuminuria were examined. RESULTS: In total, 115 patients with type 1 diabetes (10 with fulminant type 1 diabetes and 105 with acute‐onset type 1 diabetes) were included. The median glycated hemoglobin levels were significantly lower in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes 0, 3, 6 and 9 years after diabetes onset (6.5 vs 12.7%, 6.5 vs 7.9%, 6.7 vs 8.2%, 7.5 vs 8.5%, respectively). Kaplan–Meier analysis showed a significantly higher incidence rate of renal dysfunction in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes (hazard ratio 1.72, 95% confidence interval 1.01–2.97, P = 0.037). The incidence rate of microalbuminuria did not significantly differ between the groups (hazard ratio 0.97, 95% confidence interval 0.34–2.77, P = 0.95). Sensitivity analysis using age‐ and sex‐matched patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes yielded similar results. CONCLUSIONS: The risk of developing renal dysfunction is higher in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes, despite better glycemic control. John Wiley and Sons Inc. 2017-04-13 2018-01 /pmc/articles/PMC5754524/ /pubmed/28267278 http://dx.doi.org/10.1111/jdi.12652 Text en © 2017 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Takahashi, Nobuyuki Tsujimoto, Tetsuro Chujo, Daisuke Kajio, Hiroshi High risk of renal dysfunction in patients with fulminant type 1 diabetes |
title | High risk of renal dysfunction in patients with fulminant type 1 diabetes |
title_full | High risk of renal dysfunction in patients with fulminant type 1 diabetes |
title_fullStr | High risk of renal dysfunction in patients with fulminant type 1 diabetes |
title_full_unstemmed | High risk of renal dysfunction in patients with fulminant type 1 diabetes |
title_short | High risk of renal dysfunction in patients with fulminant type 1 diabetes |
title_sort | high risk of renal dysfunction in patients with fulminant type 1 diabetes |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754524/ https://www.ncbi.nlm.nih.gov/pubmed/28267278 http://dx.doi.org/10.1111/jdi.12652 |
work_keys_str_mv | AT takahashinobuyuki highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes AT tsujimototetsuro highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes AT chujodaisuke highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes AT kajiohiroshi highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes |